Show Summary Details

Quick Reference

A NSAID that selectively inhibits cyclo-oxygenase-2 (COX-2) thereby inhibiting prostaglandin, but not thromboxane synthesis, and thus having no effect on platelet aggregation or blood clotting. There is, however, an increased risk of heart attack and stroke and some drugs in this class have been withdrawn. TN Celebrex.

Subjects: Clinical Pharmacology and Therapeutics.

Reference entries

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.